Ubs Group Ag Pet Vivo Holdings, Inc. Transaction History

Ubs Group Ag

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$1.89 - $2.92 $3,171 - $4,899	1,678 New	1,678 $3,000
Q4 2022 Feb 08, 2023	SELL	$1.85 - $2.69 $2,316 - $3,367	-1,252 Reduced 24.12%	3,938 $7,000
Q3 2022 Nov 10, 2022	BUY	$0.28 - $2.89 $855 - $8,828	3,055 Added 143.09%	5,190 $10,000
Q2 2022 Aug 10, 2022	SELL	$1.3 - $2.63 $4,572 - $9,249	-3,517 Reduced 62.23%	2,135 $3,000
Q1 2022 May 16, 2022	BUY	$1.25 - $3.97 $7,065 - $22,438	5,652 New	5,652 $12,000

Ticker PETV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 10,072,000
Market Cap $4.73M
Description
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint affliction...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.